Works matching IS 10781552 AND DT 2023 AND VI 29 AND IP 4


Results: 40
    1
    2
    3
    4
    6
    7
    8
    9
    10
    11
    12

    Possible heart failure caused by osimertinib in a lung cancer patient.

    Published in:
    Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 1015, doi. 10.1177/10781552221143787
    By:
    • Ruiz-Briones, Paula;
    • Escudero-Vilaplana, Vicente;
    • Collado-Borrell, Roberto;
    • Vicente-Valor, Juan;
    • Alvarez, Rosa;
    • Villanueva-Bueno, Cristina;
    • Narrillos-Moraza, Álvaro;
    • Herranz, Ana;
    • Sanjurjo, Maria
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Lenalidomide induced pneumonitis.

    Published in:
    Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 971, doi. 10.1177/10781552221124533
    By:
    • Finch, Kelsey;
    • Sharma, Deepankar;
    • Wagner, Stephanie
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31

    EGFR-mutated advanced lung cancer. Data from a single institution, the Hospital of Leon, in Spain.

    Published in:
    Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 854, doi. 10.1177/10781552221085253
    By:
    • Delgado Sillero, Irene;
    • Lopetegui Lia, Nerea;
    • Sánchez Cousido, Luis Felipe;
    • Rojas Piedra, Mariam;
    • Távara Silva, Blanca;
    • Garrido Onecha, Maria Luisa;
    • Medina Valdivieso, Soledad;
    • Alonso Horcajo, Nieves;
    • Díez Tascón, Cristina;
    • López González, Ana;
    • Castañón López, Carmen;
    • Pedraza Lorenzo, Manuela;
    • García Palomo, Andrés;
    • Martín, Vicente;
    • Diz Tain, Pilar
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40